Search

Displaying results 9031 - 9040 of 10000 in total
  1. Drug

    Asunercept

    go.drugbank.com/drugs/DB15160
    Investigational

    Asunercept is under investigation in clinical trial NCT02853565 (A Study of CAN008 for Newly Diagnosed Glioblastoma Multiforme).

  2. Drug

    Toreforant

    go.drugbank.com/drugs/DB12522
    Investigational

    Toreforant has been used in trials studying the treatment of Asthma, Psoriasis, Hepatic Impairment, and Rheumatoid Arthritis.

  3. Drug

    Cevipabulin

    go.drugbank.com/drugs/DB12533
    Investigational

    Cevipabulin has been used in trials studying the treatment and educational/counseling/training of Tumors and Neoplasms.

  4. Drug

    Sprifermin

    go.drugbank.com/drugs/DB12616
    Investigational

    Sprifermin has been used in trials studying the treatment of Osteoarthritis, Knee and Cartilage Injury of Knee.

  5. Drug

    BMS-184476

    go.drugbank.com/drugs/DB12633
    Investigational

    BMS-184476 has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

  6. Drug

    Suptavumab

    go.drugbank.com/drugs/DB12759
    Investigational

    Suptavumab has been used in trials studying the treatment and basic science of Respiratory Syncytial Virus Infections.

  7. Drug

    Depatuxizumab

    go.drugbank.com/drugs/DB12826
    Investigational

    Depatuxizumab has been used in trials studying the treatment and diagnostic of Adenocarcinoma and Advanced Solid Tumors.

  8. Drug

    Robatumumab

    go.drugbank.com/drugs/DB12976
    Investigational

    Robatumumab has been used in trials studying the treatment of Osteosarcoma, Sarcoma, Ewing's, and Peripheral Neuroectodermal Tumor.

  9. Drug

    Simenepag isopropyl

    go.drugbank.com/drugs/DB12977
    Investigational

    Simenepag isopropyl has been used in trials studying the treatment of Ocular Hypertension and Glaucoma, Open-Angle.

  10. Drug

    NSI-189

    go.drugbank.com/drugs/DB16230
    Investigational

    NSI-189 is under investigation in clinical trial NCT02695472 (Study of NSI-189 for Major Depressive Disorder).